We provide you with 20 years of free, institutional-grade data for DICE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DICE. Explore the full financial landscape of DICE stock.
| Reported Date | CIK | Ticker | Type |
|---|
DICE Therapeutics(NASDAQ:DICE) 
DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It designs and develops therapies in immunology for patients with chroni...
Share this website to your friends
The information provided in this report about DICE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.